Posts by: Alice Melão

News

Pharmatest Services, in collaboration with Taconic Biosciences, has developed a new experimental mouse model with a human immune system specifically engineered to study bone metastasis — a frequent consequence of many ... Read more

July 11, 2017

FDA Grants Orphan Drug Status to TPX-0005 for Non-small Cell Lung Cancers with Gene Mutations

News

U.S. regulators have granted orphan drug status to TP Therapeutics’ TPX-0005 as a treatment for non-small cell lung cancers with certain gene mutations, according to a company press release. The Federation Drug ... Read more

July 6, 2017

Mutation Burden and PD-L1 Levels Can Help Predict Patient’s Response to Opdivo, Study Finds

News

Genetic characterization and the detection of PD-1 ligand protein (PD-L1) levels in non-small cell lung cancers (NSCLC) can help oncologists identify those who may benefit the most from Opdivo (nivolumab) as ... Read more

June 27, 2017June 27, 2017

Memory T-cells Within Lung Tumors Predict Good Patient Outcome, Study Shows

News

Researchers have identified a subset of immune T-cells that improve the effectiveness of immunotherapies in lung cancer, and may help identify patients more likely to respond to such therapies. Their ... Read more

June 13, 2017

Keytruda Increases Survival of Lung Cancer Patients, Compared with Standard Chemo, Update Shows

lung cancer, News

Keytruda (pembrolizumab) reduced the risk of non-small cell lung cancer patients dying by 37 percent, compared with standard chemotherapy, according to updated information from a Phase 3 clinical trial. Sixty-one percent ... Read more

May 25, 2017

EU Panel Recommends Approval of Zykadia as First-line Treatment for ALK-Positive NSCLC

News

Zykadia (ceritinib) was recommended for approval in Europe by the EMA‘s Committee for Medicinal Products for Human Use (CHMP) as first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) ... Read more